Trial intelligence / Profile preview

S-ketamine for pediatric outpatient sedation

ChiCTR2200060976Phase 4Not yet recruiting

Sponsor
Hunan Children's Hospital
Start
Jun 2022
Modality
Small Molecules
Countries
1
01

Overview

Phase 4 trial of esketamine (3 arms), sponsored by Hunan Children's Hospital. Primary endpoints: Ramsay sedation score and Steward awakening score. Planned start Jun 2022; status: not yet recruiting.

02

Drugs

esketamine

Beyond the preview

Go deeper on ChiCTR2200060976.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on ChiCTR2200060976.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call